Melanoma Clinical Trial

Clinical Trial Finder Melanoma Trials

Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

See Locations Near You

Summary

The purpose of the study is to determine if ipilimumab is effective in preventing or delaying recurrence and prolongs survival after complete resection of high risk stage III melanoma

View Eligibility Criteria

Eligibility Criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.

Inclusion Criteria:

Age ≥ 18 years
Complete and adequate resection of Stage III melanoma with histologically confirmed melanoma metastatic to lymph node
Disease-free
Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 or 1
Randomization within 12 weeks of surgery

Exclusion Criteria:

Prior therapy for melanoma except surgery
Auto-immune disease

Study is for people with:

Melanoma

Phase:

Phase 3

Estimated Enrollment:

1211

Study ID:

NCT00636168

Recruitment Status:

Completed

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 97 Locations for this study

See Locations Near You

The Angeles Clinic & Research Institute
Los Angeles California, 90025, United States
Sharp Memorial Hospital
San Diego California, 92123, United States
California Pacific Medical Center
San Francisco California, 94115, United States
North. Cal. Melanoma Center-St. Mary's Medical Center
San Francisco California, 94117, United States
Yale University School Of Medicine
New Haven Connecticut, 06520, United States
Boca Raton Comprehensive Cancer Center
Boca Raton Florida, 33428, United States
H Lee Moffitt Cancer Cnt And Res Inst
Tampa Florida, 33612, United States
Oncology Specialists, S.C.
Park Ridge Illinois, 60068, United States
Dana Farber Cancer Institute
Boston Massachusetts, 02215, United States
Washington University School Of Medicine
Saint Louis Missouri, 63110, United States
Nevada Cancer Center
Las Vegas Nevada, 89135, United States
Atlantic Melanoma Center
Morristown New Jersey, 07962, United States
University Of New Mexico Cancer Center
Albuquerque New Mexico, 87131, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States
Levine Cancer Institute
Charlotte North Carolina, 28204, United States
St Lukes Hospital And Health Network
Bethlehem Pennsylvania, 18015, United States
Vanderbilt-Ingram Cancer Ctr
Nashville Tennessee, 37232, United States
Center For Oncology Research & Treatment, P.A.
Dallas Texas, 75230, United States
Huntsman Cancer Institute At The Univ. Of Utah
Salt Lake City Utah, 84112, United States
Seattle Cancer Care Alliance
Seattle Washington, 98109, United States
Local Institution
Waratah New South Wales, 2298, Australia
Local Institution
Westmead New South Wales, 2145, Australia
Local Institution
Greenslopes Queensland, 4120, Australia
Local Institution
Woolloongabba Queensland, 4102, Australia
Local Institution
Box Hill Victoria, 3128, Australia
Local Institution
Malvern Victoria, 3144, Australia
Local Institution
Nedlands Western Australia, 6009, Australia
Local Institution
Graz , A-803, Austria
Local Institution
Wien , A-109, Austria
Local Institution
Gent , 9000, Belgium
Local Institution
Leuven , 3000, Belgium
Local Institution
Calgary Alberta, T2N 4, Canada
Local Institution
Edmonton Alberta, T6G 1, Canada
Local Institution
Montreal Quebec, H2W 1, Canada
Local Institution
Praha 2 , 128 0, Czechia
Local Institution
Praha 2 , 12808, Czechia
Local Institution
Aarhus C , 8000, Denmark
Local Institution
Herlev , DK-27, Denmark
Local Institution
Odense C , 5000, Denmark
Local Institution
Helsinki , 00029, Finland
Local Institution
Turku , 20520, Finland
Local Institution
Lillie Cedex, 59037, France
Local Institution
Boulogne-billancourt , 92104, France
Local Institution
Marseille Cedex 5 , 13885, France
Local Institution
Paris , 75010, France
Local Institution
Paris , 75018, France
Local Institution
Pierre Benite , 69495, France
Local Institution
Vandoeuvre Les Nancy , 54511, France
Local Institution
Villejuif , 94805, France
Local Institution
Berlin , 10117, Germany
Local Institution
Essen , 45122, Germany
Local Institution
Gottingen , 37075, Germany
Local Institution
Heidelberg , 69120, Germany
Local Institution
Kiel , 24105, Germany
Local Institution
Koln , 50937, Germany
Local Institution
Luebeck , 23538, Germany
Local Institution
Mannheim , 68167, Germany
Local Institution
Tubingen , 72076, Germany
Local Institution
Wurzburg , 97080, Germany
Local Institution
Genova , 16132, Italy
Local Institution
Milano , 20141, Italy
Local Institution
Napoli , 80131, Italy
Local Institution
Padova , 35128, Italy
Local Institution
Roma , 00144, Italy
Local Institution
Siena , 53100, Italy
Local Institution
Amsterdam , 1066 , Netherlands
Local Institution
Amsterdam , 1081 , Netherlands
Local Institution
Leiden , 2333 , Netherlands
Local Institution
Nijmegen , 6500 , Netherlands
Local Institution
Rotterdam , 3075E, Netherlands
Local Institution
Oslo , 0310, Norway
Local Institution
Poznan , 61-86, Poland
Local Institution
Warszawa , 02-78, Poland
Local Institution
Pyatigorsk Stavropol Region, 35750, Russian Federation
Local Institution
Ivanovo , 15301, Russian Federation
Local Institution
Izhevsk , 42600, Russian Federation
Local Institution
Krasnodar , 35004, Russian Federation
Local Institution
Krasnoyarsk , 66002, Russian Federation
Local Institution
Lipetsk , 39800, Russian Federation
Local Institution
Moscow , 11547, Russian Federation
Local Institution
Petrozavodsk , 18500, Russian Federation
Local Institution
Saratov , 41000, Russian Federation
Local Institution
St Petersburg , 19404, Russian Federation
Local Institution
St. Petersburg , 19110, Russian Federation
Local Institution
St. Petersburg , 19702, Russian Federation
Local Institution
Tomsk , 63405, Russian Federation
Local Institution
Ufa , 45005, Russian Federation
Local Institution
Barcelona , 08036, Spain
Local Institution
Madrid , 28041, Spain
Local Institution
Zaragoza , 50009, Spain
Local Institution
Stockholm , 171 7, Sweden
Local Institution
Zurich , 8091, Switzerland
Local Institution
Chelmsford Essex, CM1 7, United Kingdom
Local Institution
London Greater London, SW17 , United Kingdom
Local Institution
Southampton Hampshire, SO16 , United Kingdom
Local Institution
Nottingham Nottinghamshire, NG5 1, United Kingdom
Local Institution
Leeds Yorkshire, LS9 7, United Kingdom
Load More

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Phase:

Phase 3

Estimated Enrollment:

1211

Study ID:

NCT00636168

Recruitment Status:

Completed

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider